Targeting the heart-immune axis after myocardial infarction: from inflammation to immunomodulation - Quiz - MDSpire

Targeting the heart-immune axis after myocardial infarction: from inflammation to immunomodulation

  • By

  • Li Huang

  • Riping Xu

  • Junyu Fan

  • Liangqing Zhang

  • Min Chen

  • May 28, 2026

  • 0 min

Share

Original Source(s)

Targeting the heart-immune axis after myocardial infarction: from inflammation to immunomodulation

  • by Li Huang, Riping Xu, Junyu Fan, Liangqing Zhang, Min Chen

  • May 28, 2026

Related Content

Identification of cardiovascular disease in patients with kidney stone disease using explainable machine learning

Patients with type 1 diabetes mellitus and recommended low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B targets – a SwissDiab study

Comparative efficacy of lipid-lowering therapies on the cardio-renal-metabolic axis in diabetic kidney disease: a Bayesian network meta-analysis addressing residual CRM risk